FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称SOQUELITINIB
异名/同义词CP-000596
CPI-000818
CPI596
CPI-596
CPI818
CPI-818
CYCLOPROPANECARBOXAMIDE, N-(5-((5-(((3R)-HEXAHYDRO-3-METHYL-4-(1-OXO-2-PROPEN-1-YL)-1H-1,4-DIAZEPIN-1-YL)CARBONYL)-4-METHOXY-2-METHYLPHENYL)THIO)-2-THIAZOLYL)-
N-(5-((4-METHOXY-2-METHYL-5-((3R)-3-METHYL-4-(PROP-2-ENOYL)-1,4-DIAZEPANE-1-CARBONYL)PHENYL)SULFANYL)-1,3-THIAZOL-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
N-(5-((5-(((3R)-4-(PROP-2-ENOYL)-3-METHYL-1,4-DIAZEPAN-1-YL)CARBONYL)-4-METHOXY-2-METHYLPHENYL)SULFANYL)-1,3-THIAZOL-2-YL)CYCLOPROPANECARBOXAMIDE
SOQUELITINIB
SOQUELITINIB [INN]
SOQUELITINIB [USAN]
CAS登记号2226636-04-8
物质唯一标识(Unique Ingredient Identifier)6I5H17AN3I
分子式C25H30N4O4S2
国际化合物标识(International Chemical Identifier,InChI)KNCWSXRTKLTULH-MRXNPFEDSA-N
SMILESC(=O)(c1c(OC)cc(c(c1)Sc2sc(nc2)NC(=O)C3CC3)C)N4C[C@@H](C)N(CCC4)C(C=C)=O
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
  • 药品国际非专利名称数据库
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System